Purdue, Employees To Pay $700M In OxyContin Case

Law360, New York (May 10, 2007, 12:00 AM EDT) -- The company that makes the narcotic pain killer Oxycontin and three former executives pled guilty Thursday to charges of misbranding the drug and agreed to fork over more than $700 million in payments to the government.

Purdue Frederick Company Inc., as well as its president Michael Friedman; chief legal officer Howard Udell; and former chief medical officer Paul D. Goldenheim pled guilty in the U.S. District Court for the Western District of Virginia to a misdemeanor charge of misbranding OxyContin. The pleas come in the same...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.